Novozymes finishes difficult 2019 burdened by bioenergy

The Danish enzyme producer landed an organic growth figure of -1 percent in 2019, significantly below the company's original guidance for the year. The company moreover initiates a share buyback program of EUR 200 million.

Photo: Novozymes/PR

Log in to read our articles

Welcome to EnergyWatch. A part of our content is exclusive and reserved for our users.

Try EnergyWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles

Latest News


See all

See all